- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03249324
Preventing Obesity in Military Communities: Mother-Baby
10. August 2017 aktualisiert von: Henry M. Jackson Foundation for the Advancement of Military Medicine
Women with pre-pregnancy obesity, women who exceed recommended weight gain during pregnancy, and children who experience rapid and excess growth during the first year of life are all at risk for subsequent obesity.
The purpose of this study is to examine creative cognitive strategies to promote healthy weight gain during pregnancy, creating a sound substrate of metabolic programming for the critical first six months of life.
A trans-disciplinary approach utilizing a patient- and family-centered intervention and active patient engagement with counseling for positive gain will work with women to shape lifestyle during pregnancy and postpartum, and when feeding their infants in the first 6 months of life.
It is hypothesized patient engagement with counseling for positive gains will successfully mitigate excess weight gain in both pregnancy and infancy compared to usual care.
Moreover, data will be examined to assess whether psychological variables, work and school climate, and social support factors influence body weight gain trajectories and/or weight loss during and after pregnancy.
Studienübersicht
Status
Unbekannt
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Obesity is increasingly common among reproductive aged women and women presenting for their first pregnancy.
Women with overweight and obesity are more likely to exceed recommended weight gain during pregnancy and retain excess weight after delivery.
Women with pre-pregnancy obesity, women who exceed recommended weight gain during pregnancy, and children who experience rapid and excess growth during the first year of life are all at risk for subsequent obesity.
Additionally, maternal obesity is a significant risk factor for pregnancy complications (i.e., hypertensive disorders of pregnancy, gestational diabetes) and is associated with adverse pregnancy outcomes, including excess fetal weight at birth.
The goal of this study is to test the effectiveness of active patient engagement with counseling for positive gain to mitigate excess weight gain in women during pregnancy and postpartum, and in the first six months of life.
Pregnant women eligible to receive care in the Military Health System (MHS) will be randomized to receive either the positive-gain counseling (PGC) prevention program or usual care (UC).
PGC is designed to empower women to examine food choices and activity patterns during pregnancy to help them adhere to the Institute of Medicine (IOM) recommended weight gain standards.
PGC patients will be paired with counselors who follow their pregnancy from start to finish, as well as providing neonatal and infant support in a continuous fashion as part of team-based care.
Women in the usual care (UC) group will receive prenatal care in accordance with the VA/DoD Guideline for the Management of Pregnancy.
Both groups will receive routine well-child care in accordance with established guidelines from the American Academy of Pediatrics and the American Academy of Family Physicians.
Routine well-child care appointments (UC) take place at 2-3 days after birth, 2 weeks of life, 2 months of life, 4 months, 6 months, 9 months and 12 months.
Participants' weight status, food intake, and mood will be assessed once during each trimester and at 2 weeks, 2 months, 4 months, and 6 months postpartum.
Individuals enrolled in the PGC group will receive specific counseling once during each trimester and at 2 weeks, 2 months, 4 months and 6 months postpartum.
Well-child sessions will focus on positive-gain-based cognitive strategies to promote breastfeeding, recognition of satiety cues and other healthy food choices.
It is hypothesized that participants who receive the positive-gains counseling program will show significantly less weight gain in both pregnancy and infancy relative to those randomized to usual care.
Studientyp
Interventionell
Einschreibung (Tatsächlich)
58
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
North Carolina
-
Camp Lejeune, North Carolina, Vereinigte Staaten, 28547
- Naval Hospital Camp Lejeune
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
18 Jahre bis 35 Jahre (Erwachsene)
Akzeptiert gesunde Freiwillige
Ja
Studienberechtigte Geschlechter
Weiblich
Beschreibung
Inclusion Criteria:
- Age between 18 and 35 years
- Absence of underlying medical conditions that would place the pregnancy in the high-risk category (e.g., hypertension, pre-existing diabetes mellitus, thyroid disease, multiple gestations)
- Baseline BMI (on determination of pregnancy) >18 kg/m2 and ≤29.9 kg/m2
- Plan to reside in the study area (Jacksonville, NC area) for at least 18 months
- Eligible for care within the Military Health System (MHS)
- No planned surgeries, medical interventions, or other procedures that would place participants in the high-risk pregnancy category
- No involvement in a commercial or military weight management program in the past 3 months
- Fluent command of the English language
Exclusion Criteria:
- Current involvement in a structured weight loss program
- BMI of ≤18 kg/m2 or ≥30 kg/m2
- Potential participants with high-risk pregnancies. Participants will be placed in the high risk pregnancy category if they have any underlying medical conditions (e.g. hypertension, diabetes, thyroid disease, multiple gestations) placing the subject into a high-risk category by American College of Obstetrics and Gynecology (ACOG) standards
- Planned surgeries or other procedures that would place participants in the high-risk pregnancy category
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Positive-Gain Counseling (PGC)
Positive-gain-based health promotion interventions capitalize on the basic human desire to maintain consistency between one's words and actions for beneficial outcomes.
Participants will discuss potential costs of unhealthy behaviors and the benefits of healthier lifestyle choices, and how they apply not only to adults, but also to developing children.
Theoretically, discussing these perspectives will make the mothers more likely to make healthier lifestyle choices in the future.
|
Positive-gain-based health promotion interventions capitalize on the basic human desire to maintain consistency between one's words and actions for beneficial outcomes.
Participants will be asked to discuss potential adverse effects of obesity, an unhealthy diet, and sedentary behavior, as well as the benefits of maintaining a physically fit body, eating a healthy diet, and regular physical activity.
They will also discuss the costs and benefits as they apply to developing children.
Theoretically, discussing and reviewing these perspectives will make the mothers more apt to make healthier lifestyle choices in the future.
Women randomized to the positive-gains counseling (PGC) group will have PGC sessions once during each trimester and at 2 weeks, 2 months, 4 months and 6 months postpartum.
PGC participants will also receive prenatal care in accordance with the VA/DoD Guideline for the Management of Pregnancy.
|
Aktiver Komparator: Usual Care (UC)
UC includes regular clinic visits, routine blood and urine screening tests, and anticipatory guidance from a primary care provider in accordance with the VA/DoD Guideline for the Management of Pregnancy.
After delivery, participants receive routine well-child care in accordance with established guidelines from the American Academy of Pediatrics and the American Academy of Family Physicians.
|
Women in the usual care (UC) group will receive prenatal care in accordance with the VA/DoD Guideline for the Management of Pregnancy.
This entails regular clinic visits, routine blood and urine screening tests, and anticipatory guidance.
Routine well-child care appointments will take place at 2-3 days, 2 weeks, 2 months, 4 months, 6 months, 9 months and 12 months after birth.
During routine well-child visits, height, weight, and vital signs are measured, developmental milestones are reviewed, and a thorough physical examination is performed.
Age-appropriate immunizations are provided as is parental anticipatory guidance, including the importance of breastfeeding.
Participants enrolled in the UC group will receive anticipatory guidance from their primary care provider in the usual fashion.
Providers will deliver this anticipatory guidance with no external cues or counseling provided by the research team.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
---|---|
Maternal weight gain
Zeitfenster: Pre-pregnancy to delivery
|
Pre-pregnancy to delivery
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Infant birth weight
Zeitfenster: Birth
|
Data will be collected from the participant's inpatient medical records (Essentris) at Naval Hospital Camp Lejeune
|
Birth
|
Development of gestational diabetes
Zeitfenster: Gestation
|
Data will be collected for all participants from the outpatient electronic medical records (AHLTA) at Naval Hospital Camp Lejeune
|
Gestation
|
Need for induction of labor and methods of labor induction used
Zeitfenster: Labor and delivery
|
Data will be collected from the participant's inpatient medical records (Essentris) at Naval Hospital Camp Lejeune
|
Labor and delivery
|
Mode of Delivery
Zeitfenster: Birth
|
Mode of delivery (e.g., vaginal or Caesarean section) will be collected from the participant's inpatient medical records (Essentris) at Naval Hospital Camp Lejeune
|
Birth
|
Length of Labor
Zeitfenster: Onset of latent phase of labor to delivery of the placenta and fetal membranes
|
The length of labor will be collected from the participant's inpatient medical records (Essentris) at Naval Hospital Camp Lejeune
|
Onset of latent phase of labor to delivery of the placenta and fetal membranes
|
Need for anesthesia or analgesics and forms of anesthesia or analgesics used during labor
Zeitfenster: Labor and delivery
|
Data will be collected from the participant's inpatient medical records (Essentris) at Naval Hospital Camp Lejeune
|
Labor and delivery
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Mitarbeiter
Ermittler
- Hauptermittler: Mark Stephens, MD, Uniformed Services University of the Health Sciences
- Hauptermittler: Linda Chan, MD, Naval Hospital Camp Lejeune
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn
1. November 2014
Primärer Abschluss (Voraussichtlich)
1. September 2017
Studienabschluss (Voraussichtlich)
1. September 2017
Studienanmeldedaten
Zuerst eingereicht
20. Juni 2017
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
10. August 2017
Zuerst gepostet (Tatsächlich)
15. August 2017
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
15. August 2017
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
10. August 2017
Zuletzt verifiziert
1. August 2017
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- NHCL.2012.0011
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
NEIN
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .